AgenDx Biosciences Company
AgenDx is an early stage molecular diagnostics company develops a revolutionary cost-effective molecular diagnostics platform.
Last Funding Type:
Post-IPO Debt
Funding Status:
Seed
Headquarters:
South Bend, Indiana, United States
Industry:
Deep Diagnostics
Investor Type:
For Profit
Estimated Revenue:
$1M to $10M
Technology:
Genetic Test & Molecular Diagnostics
Total Funding:
$39.4M
Investors Number:
2
Employee Number:
1-10
Founded Date:
01.01.2014